Pharmafile Logo
Pharmafocus logo
Advanced Search
astrazeneca-sign

AZ’s lupus drug fails to curb lupus activity at Phase 3

August 31, 2018
Medical Communications, Research and Development AstraZeneca, Lupus, anifrolumab, pharma

AstraZeneca and its biologics R&D arm MedImmune have released a statement admitting that their fully human monoclonal antibody anifrolumab failed …

News

Bristol-Myers Squibb appoints Christopher Boerner as new Executive Vice President and Chief Commercial Officer

August 30, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, bristol myers squibb, cco, chief commercial officer, christopher boerner, executive vice president, murdo gordon

Bristol Myers Squibb has announced that Dr Christopher Boerner will take over from Murdo Gordon as executive Vice President and …

Appointment
credit_natural_cycles

Contraceptive app Natural Cycles investigated over “misleading” efficacy claims

August 30, 2018
Medical Communications, Sales and Marketing APP Pharma, Natural Cycles, UK, app. pharma

The company behind Natural Cycles, the first-ever approved smartphone app promising a natural alternative to contraception, has seen a Facebook …

News
psm_v46_d168_mesial_view_of_the_human_brain

Drug slows brain shrinkage associated with progressive multiple sclerosis, study shows

August 30, 2018
Research and Development MS, brain, ibudilast, neuroscience, research

The multiple sclerosis drug ibudilast, slowed brain shrinkages in patients with progressive MS, a study published in the New England …

News
medicinal_cannabis_uk_review

CBD dampens activity in brain regions associated with psychosis, study shows

August 30, 2018
Research and Development CBD, King's College London, Kings College London, Marijuana, psychosis, study

Cannabidiol (CBD), one of the major constituents of cannabis, may be beneficial for patients with psychotic disorders due to its …

News
astrazeneca_building_white

AstraZeneca’s once-weekly auto-injector Bydureon BCise wins EU approval in type 2 diabetes

August 30, 2018
Research and Development, Sales and Marketing AstraZeneca, Bydureon, EU, Europe, diabetes, pharma, type 2 diabetes

AstraZeneca has announced that its auto-injector Bydureon BCise (exenatide 2mg prolonged-release suspension) has been approved by the European Commission for …

News
shutterstock_4030507

Opioid prescriptions hit 15 year low, as FDA’s Gottlieb reaffirms commitment against crisis

August 30, 2018
Medical Communications FDA, opioid crisis, prescriptions, scott gottleib

The amount of opioids prescribed to patients in the United States has fallen to a 15 year low according to …

News
jazz_pharma

Jazz Pharma’s acute myeloid leukaemia drug scores EU approval

August 29, 2018
Research and Development, Sales and Marketing Vyxeos, acute myeloid leukaemia, jazz pharmaceuticals, leukaemia, pharma

Jazz Pharmaceuticals has revealed that its advanced liposomal formulation Vyxeos has received approval from the European Commission for the treatment …

News
shutterstock_168864905

Emergent snaps up Adapt and its opioid overdose therapy for $735m

August 29, 2018
Research and Development, Sales and Marketing Emergent, Narcan, naloxone, opioid crisis, opioids, pharma

Emergent BioSolutions has announced it has signed an agreement to acquire Adapt Pharma at a valuation of $735 million, a …

News

NHS guidance suggests mental health therapists should be brought into GP surgeries

August 29, 2018
Research and Development England, GP, NHS, guidance, psychology, psychotherapy

New NHS guidelines will encourage doctors to incorporate mental health therapists into practice surgeries in an effort to bring more …

News
16792957331_d9572dbdf4_z

FDA warns against King Bio products after company expands recall

August 29, 2018
Research and Development Contamination, FDA, homeopathy, king bio, recall

The US Food and Drug Administration is warning consumers and pet owners not to use products that have been manufactured …

News
novartis_mit_us

Novartis to create 450 new jobs at Aargau site after Kymriah thumbs up

August 29, 2018
Research and Development CAR T, CAR-T, Jobs, Kymriah, Novartis

Swiss multinational Novartis is set to create up to 450 new jobs following the investment of 90 million Swiss Francs …

News
eisa0008_web

Eisai’s weight loss drug lorcaserin found safe in major study

August 28, 2018
Manufacturing and Production, Research and Development, Sales and Marketing Eisai, lorcaserin, safety, study, weight loss

Eisai’s weight loss drug lorcaserin does not increase people’s risk of major cardiovascular events according to a study of 12,000 …

News

Ionis/Akcea’s ultra-rare disease drug rejected by FDA

August 28, 2018
Manufacturing and Production, Sales and Marketing Akcea, FDA, Ionis, familial chylomicronemia syndrome, pharma, rare disease

The FDA has opted to refuse approval to Akcea and Ionis’ Waylivra (volanesorsen) for the treatment of the ultra-rare hereditary …

News
26022266362_1bf5a2747e_z

Researchers develop anti-nicotine addiction drugs

August 28, 2018
Manufacturing and Production, Research and Development, Sales and Marketing addiction, candidates, drug, nicotine, research, washington state university

Washington State University researchers have developed an array of drug candidates which they believe may help tackle addiction to nicotine. …

News
european_commission_web

Novartis’ Kymriah & Gilead’s Yescarta become first EU-approved CAR T therapies

August 28, 2018
Manufacturing and Production, Sales and Marketing CAR T, CAR-T, Cancer, EU, Gilead, Kymriah, Novartis, UK, Yescarta, blood cancer, pharma

Almost one full year since the treatment was given a “historic” approval in the US, Novartis’ CAR T therapy Kymriah …

News
social_media_phone_iphone_twitter_hand-38920

Russian trolls spread vaccine misinformation on Twitter

August 28, 2018
Manufacturing and Production, Medical Communications, Sales and Marketing Russia, misinformation, public health, study, vaccines

Twitter bots and Russian trolls post content about vaccination at significantly higher rates than normal users, a new study has …

News

Dompé gives the FDA its first approved neurotrophic keratitis treatment

August 24, 2018
Medical Communications, Sales and Marketing Dompe, FDA, Oxervate, eye disease, pharma

Milan-based biotech firm Dompé has revealed that the FDA has awarded approval in the US to its Oxervate (cenegermin-bkbj ophthalmic …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

August 24, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing India, Ireland, manufacturin, san francisco, top 10

As summer comes to an end manufacturing dominated the news, with jobs lost in both Ireland and San Francisco. Meanwhile …

News
natural-homeopathic-remedy-alternative-homeopathy-1604071

Homeopathic medicines specialist King Bio enacts nationwide recall

August 24, 2018
Medical Communications asheville, homeopathy, king bio, nc, recall

The Asheville-based drug maker King Bio is recalling 32 children’s medicines because of potential ‘microbial contamination’. The homeopathic medicines specialist …

News
The Gateway to Local Adoption Series

Latest content

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026